CClinicalTrials.gg
Sign In
RecruitingNCT07163832TRANSUpdated Sep 9, 2025

Retrospective Study of the Cohort of Transgender Patients Who Began Medical Support Before the Age of 18

An observational study in Endocrinology, sponsored by University Hospital, Strasbourg, France. Recruiting at 1 site in France. Open to participants aged 8 Years to 17 Years. Per ClinicalTrials.gov, last updated 2025-09-09.

Sponsored by University Hospital, Strasbourg, France · Observational

From the registry’s dates

  • Primary completion was expected by May 2026, 5 months ago, but the record still lists the study as recruiting.
  • Started May 2025; still recruiting 1 year 4 months later.
Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
115
Ages
8 Years to 17 Years
Sex
All
01

Study summary

Gender incongruence is characterized by a marked and persistent incongruity between the gender with which a person identifies and their assigned sex. Behaviors and preferences that vary by sex do not, in and of themselves, justify the assignment of diagnoses in this group.

02

Conditions studied

  • Endocrinology

Keywords

  • Pediatric endocrinology
  • Child Psychiatry
03

In context

Lead sponsor

University Hospital, Strasbourg, France is the lead sponsor of 966 studies on the registry; 342 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
8 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Minor patient (≥18 years old) who has been consulted for the first time for transgender issues at the Strasbourg University Hospital in child psychiatry and/or pediatric endocrinology (in at least one of the two departments)

Inclusion criteria

  • Minor patient (≥18 years old)
  • First-time patient for transgender issues at the Strasbourg University Hospital in child psychiatry and/or pediatric endocrinology (in at least one of the two departments)
  • Patient (and/or their legal representative) who has not expressed opposition to the reuse of their data for scientific research purposes.

Exclusion criteria

Exclusion Criteria:

  • Patient (and/or their representative) who has expressed opposition to the reuse of their data for scientific research purposes.
  • Patient aged over 18 at the first consultation
  • Patient with insufficient data
05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
115 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Retrospective descriptive study of the population of transgender minors receiving medical support at the Strasbourg University Hospital

    Time frame: Up to 1 year

07

Study locations

1 of 1 sites recruiting
  • Service de pédiatrie 1 - CHU de Strasbourg - France
    Strasbourg, 67091, France
    • François BREZIN, MD · Contact · francois.brezin@chru-strasbourg.fr · 03.88.12.77.34
    • François BREZIN, MD · Principal investigator
    • Camille SCHUNDER, MD · Sub investigator
    • Agnes GRAS-VINCENDON, MD · Sub investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 9, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07163832
Lead sponsor
University Hospital, Strasbourg, France
Responsible party
Sponsor
First posted
Sep 9, 2025
Start date
May 15, 2025
Primary completion
May 2026 (estimated)
Completion
May 15, 2026 (estimated)
Last update
Sep 9, 2025

Study contacts

François BREZIN, MD
Contact
francois.brezin@chru-strasbourg.fr
03.88.12.77.34

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

University Hospital, Strasbourg, France

Start the discussion